NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55,196 | -29.2% | 24,423 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $78,000 | -25.0% | 24,423 | -10.9% | 0.01% | -28.6% |
| Q2 2022 | $104,000 | +38.7% | 27,412 | +97.1% | 0.01% | +40.0% |
| Q1 2022 | $75,000 | -88.0% | 13,906 | -59.5% | 0.01% | -78.3% |
| Q3 2019 | $626,000 | -11.3% | 34,367 | +73.3% | 0.05% | -17.9% |
| Q2 2019 | $706,000 | +6.0% | 19,834 | 0.0% | 0.06% | -11.1% |
| Q1 2019 | $666,000 | -2.9% | 19,834 | -5.0% | 0.06% | +12.5% |
| Q4 2018 | $686,000 | +259.2% | 20,878 | +34.0% | 0.06% | +194.7% |
| Q1 2017 | $191,000 | 0.0% | 15,584 | 0.0% | 0.02% | -26.9% |
| Q4 2016 | $191,000 | – | 15,584 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |